Published in
Wiley, Arthritis and Rheumatology, 3(74), p. 527-540, 2022
DOI: 10.1002/art.41949
Links
Tools
Predictors of Rheumatic Immune‐Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer
Journal article published in 2022 by
Amy Cunningham‐Bussel 
,
Jiaqi Wang,
Lauren C. Prisco,
Lily W. Martin,
Kathleen M. M. Vanni ,
Alessandra Zaccardelli,
Mazen Nasrallah,
Lydia Gedmintas,
Lindsey A. MacFarlane,
Nancy A. Shadick ,
Mark M. Awad,
Osama Rahma,
Nicole R. LeBoeuf,
Ellen M. Gravallese,
Jeffrey A. Sparks
,
Jiaqi Wang,
Lauren C. Prisco,
Lily W. Martin,
Kathleen M. M. Vanni ,
Alessandra Zaccardelli,
Mazen Nasrallah,
Lydia Gedmintas,
Lindsey A. MacFarlane,
Nancy A. Shadick ,
Mark M. Awad,
Osama Rahma,
Nicole R. LeBoeuf,
Ellen M. Gravallese,
Jeffrey A. Sparks
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 